Cart is empty Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus infections. However, the ongoing evolution of the virus regularly produces new variants that are no longer neutralized by the antibodies.
Leave A Comment